← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Intrinsic Lifesciences, Llc
La Jolla, CA
$9,986,721
Total funding
5
Grants
Funding over time
peak $1.8M · FY2009–23$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$9,986,721 · 5
By mechanism
R44$8,930,024 · 3
R43$1,056,697 · 2
Investigators at Intrinsic Lifesciences, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Serum Hepcidin Immunoassay: Laboratory to Marketplace$1,465,629
R44 · FY2014 · DK
Serum Hepcidin Immunoassay: Laboratory to Marketplace$1,391,549
R44 · FY2015 · DK
Serum Hepcidin Immunoassay: Laboratory to Marketplace$1,368,932
R44 · FY2016 · DK
Novel Point-of-Care Device for Urinary Hepcidin to Detect Iron Deficiency in Children and Adolescents$960,522
R44 · FY2022 · DK
Monoclonal Sandwich ELISA for Serum Erythroferrone for Clinical Assessment of Ineffective Erythropoiesis$810,487
R44 · FY2017 · DK
Novel Point-of-Care Device for Urinary Hepcidin to Detect Iron Deficiency in Children and Adolescents$788,664
R44 · FY2023 · DK
Monoclonal Sandwich ELISA for Serum Erythroferrone for Clinical Assessment of Ineffective Erythropoiesis$676,117
R44 · FY2018 · DK
Serum Hepcidin Immunoassay: Laboratory to Marketplace$655,132
R44 · FY2012 · DK
Serum Hepcidin Immunoassay: Laboratory to Marketplace$631,188
R44 · FY2011 · DK
Hepcidin Lateral Flow Device for Prediction of Acute Kidney Injury$364,451
R43 · FY2013 · DK
Serum Hepcidin Immunoassay: Laboratory to Marketplace$356,360
R43 · FY2009 · DK
Hepcidin Lateral Flow Device for Prediction of Acute Kidney Injury$335,886
R43 · FY2014 · DK
supplemental funding for Phase 2B NIDDK grant$181,804
R44 · FY2016 · DK